Selected research
Industry Research
Smart Therapies Industry Research Report 2026
Market perspective
The global Smart Therapies market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Smart Therapies market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Smart Therapies market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Smart Therapies market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Smart Therapies include Microsot Healthcare, Tempus, Flatiron Health, 23andMe, Verly Life Sciences, Roche, IBM Watson Health, Google Health and Amazon Web Services (AWS) Healthcare. among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Smart Therapies market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Smart Therapies.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Smart Therapies Market by Company
Microsot Healthcare
Tempus
Flatiron Health
23andMe
Verly Life Sciences
Roche
IBM Watson Health
Google Health
Amazon Web Services (AWS) Healthcare
Smart Therapies Segment by Type
Artificial Intelligence
Machine Learning
Digital Health Tools
Others
Smart Therapies Segment by Application
Hospitals & Clinics
Pharmaceutical Companies
Research Institutions
Smart Therapies Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Smart Therapies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Smart Therapies and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Smart Therapies.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Smart Therapies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Artificial Intelligence
- Machine Learning
- Digital Health Tools
- Others
Applications
- Hospitals & Clinics
- Pharmaceutical Companies
- Research Institutions
Companies covered
- Microsot Healthcare
- Tempus
- Flatiron Health
- 23andMe
- Verly Life Sciences
- Roche
- IBM Watson Health
- Google Health
- Amazon Web Services (AWS) Healthcare
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Smart Therapies by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Artificial Intelligence
- 2.2.3 Machine Learning
- 2.2.4 Digital Health Tools
- 2.2.5 Others
- 2.3 Smart Therapies by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospitals & Clinics
- 2.3.3 Pharmaceutical Companies
- 2.3.4 Research Institutions
- 2.4 Assumptions and Limitations
3 Smart Therapies Breakdown Data by Type
- 3.1 Global Smart Therapies Historic Market Size by Type (2021-2026)
- 3.2 Global Smart Therapies Forecasted Market Size by Type (2027-2032)
4 Smart Therapies Breakdown Data by Application
- 4.1 Global Smart Therapies Historic Market Size by Application (2021-2026)
- 4.2 Global Smart Therapies Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Smart Therapies Market Perspective (2021-2032)
- 5.2 Global Smart Therapies Growth Trends by Region
- 5.2.1 Global Smart Therapies Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Smart Therapies Historic Market Size by Region (2021-2026)
- 5.2.3 Smart Therapies Forecasted Market Size by Region (2027-2032)
- 5.3 Smart Therapies Market Dynamics
- 5.3.1 Smart Therapies Industry Trends
- 5.3.2 Smart Therapies Market Drivers
- 5.3.3 Smart Therapies Market Challenges
- 5.3.4 Smart Therapies Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Smart Therapies Players by Revenue
- 6.1.1 Global Top Smart Therapies Players by Revenue (2021-2026)
- 6.1.2 Global Smart Therapies Revenue Market Share by Players (2021-2026)
- 6.2 Global Smart Therapies Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Smart Therapies Head Office and Area Served
- 6.4 Global Smart Therapies Players, Product Type & Application
- 6.5 Global Smart Therapies Manufacturers Established Date
- 6.6 Global Smart Therapies Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Smart Therapies Market Size (2021-2032)
- 7.2 North America Smart Therapies Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Smart Therapies Market Size by Country (2021-2026)
- 7.4 North America Smart Therapies Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Smart Therapies Market Size (2021-2032)
- 8.2 Europe Smart Therapies Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Smart Therapies Market Size by Country (2021-2026)
- 8.4 Europe Smart Therapies Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Smart Therapies Market Size (2021-2032)
- 9.2 Asia-Pacific Smart Therapies Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Smart Therapies Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Smart Therapies Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Smart Therapies Market Size (2021-2032)
- 10.2 South America Smart Therapies Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Smart Therapies Market Size by Country (2021-2026)
- 10.4 South America Smart Therapies Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Smart Therapies Market Size (2021-2032)
- 11.2 Middle East & Africa Smart Therapies Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Smart Therapies Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Smart Therapies Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Microsot Healthcare
- 12.1.1 Microsot Healthcare Company Information
- 12.1.2 Microsot Healthcare Business Overview
- 12.1.3 Microsot Healthcare Revenue in Smart Therapies Business (2021-2026)
- 12.1.4 Microsot Healthcare Smart Therapies Product Portfolio
- 12.1.5 Microsot Healthcare Recent Developments
- 12.2 Tempus
- 12.2.1 Tempus Company Information
- 12.2.2 Tempus Business Overview
- 12.2.3 Tempus Revenue in Smart Therapies Business (2021-2026)
- 12.2.4 Tempus Smart Therapies Product Portfolio
- 12.2.5 Tempus Recent Developments
- 12.3 Flatiron Health
- 12.3.1 Flatiron Health Company Information
- 12.3.2 Flatiron Health Business Overview
- 12.3.3 Flatiron Health Revenue in Smart Therapies Business (2021-2026)
- 12.3.4 Flatiron Health Smart Therapies Product Portfolio
- 12.3.5 Flatiron Health Recent Developments
- 12.4 23andMe
- 12.4.1 23andMe Company Information
- 12.4.2 23andMe Business Overview
- 12.4.3 23andMe Revenue in Smart Therapies Business (2021-2026)
- 12.4.4 23andMe Smart Therapies Product Portfolio
- 12.4.5 23andMe Recent Developments
- 12.5 Verly Life Sciences
- 12.5.1 Verly Life Sciences Company Information
- 12.5.2 Verly Life Sciences Business Overview
- 12.5.3 Verly Life Sciences Revenue in Smart Therapies Business (2021-2026)
- 12.5.4 Verly Life Sciences Smart Therapies Product Portfolio
- 12.5.5 Verly Life Sciences Recent Developments
- 12.6 Roche
- 12.6.1 Roche Company Information
- 12.6.2 Roche Business Overview
- 12.6.3 Roche Revenue in Smart Therapies Business (2021-2026)
- 12.6.4 Roche Smart Therapies Product Portfolio
- 12.6.5 Roche Recent Developments
- 12.7 IBM Watson Health
- 12.7.1 IBM Watson Health Company Information
- 12.7.2 IBM Watson Health Business Overview
- 12.7.3 IBM Watson Health Revenue in Smart Therapies Business (2021-2026)
- 12.7.4 IBM Watson Health Smart Therapies Product Portfolio
- 12.7.5 IBM Watson Health Recent Developments
- 12.8 Google Health
- 12.8.1 Google Health Company Information
- 12.8.2 Google Health Business Overview
- 12.8.3 Google Health Revenue in Smart Therapies Business (2021-2026)
- 12.8.4 Google Health Smart Therapies Product Portfolio
- 12.8.5 Google Health Recent Developments
- 12.9 Amazon Web Services (AWS) Healthcare
- 12.9.1 Amazon Web Services (AWS) Healthcare Company Information
- 12.9.2 Amazon Web Services (AWS) Healthcare Business Overview
- 12.9.3 Amazon Web Services (AWS) Healthcare Revenue in Smart Therapies Business (2021-2026)
- 12.9.4 Amazon Web Services (AWS) Healthcare Smart Therapies Product Portfolio
- 12.9.5 Amazon Web Services (AWS) Healthcare Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst